Unknown

Dataset Information

0

Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.


ABSTRACT: Oil-in-water emulsions have been successfully used to increase the efficacy, immunogenicity, and cross-protection of human vaccines; however, their mechanism of action is still largely unknown. Nlrp3 inflammasome has been previously associated to the activity of alum, another adjuvant broadly used in human vaccines, and MyD88 adaptor protein is required for the adjuvanticity of most Toll-like receptor agonists. We compared the contribution of Nlrp3 and MyD88 to the adjuvanticity of alum, the oil-in-water emulsion MF59, and complete Freund's adjuvant in mice using a three-component vaccine against serogroup B Neisseria meningitidis (rMenB). Although the basal antibody responses to the nonadjuvanted rMenB vaccine were largely dependent on Nlrp3, the high-level antibody responses induced by alum, MF59, or complete Freund's adjuvant did not require Nlrp3. Surprisingly, we found that MF59 requires MyD88 to enhance bactericidal antibody responses to the rMenB vaccine. Because MF59 did not activate any of the Toll-like receptors in vitro, we propose that MF59 requires MyD88 for a Toll-like receptor-independent signaling pathway.

SUBMITTER: Seubert A 

PROVIDER: S-EPMC3131326 | biostudies-literature | 2011 Jul

REPOSITORIES: biostudies-literature

altmetric image

Publications

Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88.

Seubert Anja A   Calabro Samuele S   Santini Laura L   Galli Barbara B   Genovese Alessia A   Valentini Sara S   Aprea Susanna S   Colaprico Annalisa A   D'Oro Ugo U   Giuliani Marzia M MM   Pallaoro Michele M   Pizza Mariagrazia M   O'Hagan Derek T DT   Wack Andreas A   Rappuoli Rino R   De Gregorio Ennio E  

Proceedings of the National Academy of Sciences of the United States of America 20110620 27


Oil-in-water emulsions have been successfully used to increase the efficacy, immunogenicity, and cross-protection of human vaccines; however, their mechanism of action is still largely unknown. Nlrp3 inflammasome has been previously associated to the activity of alum, another adjuvant broadly used in human vaccines, and MyD88 adaptor protein is required for the adjuvanticity of most Toll-like receptor agonists. We compared the contribution of Nlrp3 and MyD88 to the adjuvanticity of alum, the oil  ...[more]

Similar Datasets

| S-EPMC3632354 | biostudies-literature
| S-EPMC6912448 | biostudies-literature
| S-EPMC2768485 | biostudies-literature
| S-EPMC4481133 | biostudies-literature
| S-EPMC8305203 | biostudies-literature
| S-EPMC3270266 | biostudies-literature
| S-EPMC3351582 | biostudies-literature
| S-EPMC5015487 | biostudies-literature
| S-EPMC8921257 | biostudies-literature
| S-EPMC8491766 | biostudies-literature